Single-Chamber and Dual-Chamber Pacemaker Devices in Adults with Moderate and Complex Congenital Heart Disease: A Single Tertiary Referral Center Experience.
Congenital Heart Disease
Endocarditis
Lead Failure
Pacemaker
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
14 Feb 2024
14 Feb 2024
Historique:
received:
09
12
2023
accepted:
06
02
2024
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
14
2
2024
Statut:
aheadofprint
Résumé
The number of device implantation procedures has increased in adult patients with congenital heart disease (ACHD). Despite significant improvements in materials and implantation techniques, these patients are exposed to higher risk of device related complications than general population. Herein, we describe our single tertiary referral center experience on transvenous pacemaker (PM) implantation and follow-up in adult patients with moderate and complex congenital heart disease (CHD) as limited data are available on long-term outcome. We considered all adults with moderate and complex CHD aged more than 16 years who underwent transvenous single-chamber and dual-chamber PM implant for sinus node dysfunction or atrioventricular block between January 2013 to December 2022 at our Unit. Seventy-one ACHD patients were included in the study (mean age 38.6 ± 15.2 years, 64% with moderate CHD, 36% with complex CHD). Among 32 patients implanted with a dual chamber PM (DDD PM), 4 devices were reprogrammed in VDD mode, 3 in VVI and 2 in AAI mode during follow-up because of lead dysfunction or permanent atrial arrhythmia. In addition, 26 patients had a single chamber PM (AAI or VVI PM) and 13 patients had single-lead pacing system with a free-floating atrial electrode pair (VDD PM). Just one of 13 single-lead VDD PM was reprogrammed in VVI mode due to a low atrial sensing. In DDD PM group, 10 re-interventions were needed due to lead dysfunction (8 cases) and lead-related infective endocarditis (2 cases). Only 3 patients in the single-lead PM group developed lead dysfunction with 2 re-interventions needed, but no infective endocarditis was reported. The rate of long-term complications is high in moderate and complex ACHD with transvenous PM devices, and it is mainly lead-related. In our experience, the less leads implanted, the less complications will occur. Considering the heterogeneity of the ACHD population, transvenous single-chamber or dual-chamber PM device implantation should always be tailored on the single patient, balancing risks and benefits in this complex population.
Identifiants
pubmed: 38353710
doi: 10.1007/s00246-024-03444-6
pii: 10.1007/s00246-024-03444-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, Keavney BD (2019) Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 48(2):455–463. https://doi.org/10.1093/ije/dyz009 PMID: 30783674; PMCID: PMC6469300
doi: 10.1093/ije/dyz009
pubmed: 30783674
pmcid: 6469300
Barracano R, Ciriello GD, Sarubbi B (2023) Pharmacological therapy in adult congenital heart disease with coronary artery disease and atrial fibrillation. Int J Cardiol Congenital Heart Disease 12:2666–6685. https://doi.org/10.1016/j.ijcchd.2023.100446
doi: 10.1016/j.ijcchd.2023.100446
Brida M, Gatzoulis MA (2019) Adult congenital heart disease: past, present and future. Acta Paediatr 108(10):1757–1764. https://doi.org/10.1111/apa.14921 Epub 2019 Aug 18. PMID: 31254360
doi: 10.1111/apa.14921
pubmed: 31254360
Anderson RH, Ho SY (1991) The disposition of the conduction tissues in congenitally malformed hearts with reference to their embryological development. J Perinat Med 19(Suppl 1):201–206
pubmed: 1779360
Limongelli G, Ducceschi V, D’Andrea A, Renzulli A, Sarubbi B, De Feo M, Cerasuolo F, Calabrò R, Cotrufo M (2003) Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart 89(8):901–904. https://doi.org/10.1136/heart.89.8.901 PMID: 12860869; PMCID: PMC1767749
doi: 10.1136/heart.89.8.901
pubmed: 12860869
pmcid: 1767749
Sarubbi B, Ciriello GD, Papaccioli G et al (2023) Combined subcutaneous implantable cardioverter defibrillator and pacemaker devices in complex congenital heart disease. A single-center experienced based study. Authorea January 30. https://doi.org/10.22541/au.167507359.94643473/v1
Li W, Sarubbi B, Somerville J (2000) Iatrogenic ventricular tachycardia from endocardial pacemaker late after repair of tetralogy of Fallot. Pacing Clin Electrophysiol.;23(12):2131-4. https://doi.org/10.1111/j.1540-8159.2000.tb00789.x . PMID: 11202260
Hernández-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K, ESC Scientific Document Group (2018);. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace.;20(11):1719–1753. https://doi.org/10.1093/europace/eux380 . PMID: 29579186
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller G-P, Kluin BlungJ, Irene M, Lang F, Meijboom P, Moons, Barbara JM, Mulder E, Oechslin JW, Roos-Hesselink M, Schwerzmann L, Sondergaard K, Zeppenfeld, February, ESC Scientific Document Group (2021), 2020 ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Adult Congenital Heart Disease (ISACHD), European Heart Journal, Volume 42, Issue 6, 7 Pages 563–645, https://doi.org/10.1093/eurheartj/ehaa554
Glikson M, Nielsen JC, Kronborg MB et al (2021) 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 42(35):3427–3520
doi: 10.1093/eurheartj/ehab364
pubmed: 34455430
Stout KK, Daniels CJ, Aboulhosn JA et al (2019) 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. J Am Coll Cardiol 73(12):1494–1563
doi: 10.1016/j.jacc.2018.08.1028
pubmed: 30121240
Cecchin DG, Halpern (2017) Cardiac arrhythmias in adults with congenital heart disease: pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices. Card Electrophysiol Clin 9:319–328
Lin A, Mahle WT, Frias PA, Fischbach PS, Kogon BE, Kanter KR et al (2010) Early and delayed atrioventricular conduction block after routine surgery for congenital heart disease. J Thorac Cardiovasc Surg 140:158–160
doi: 10.1016/j.jtcvs.2009.12.050
pubmed: 20381087
Sarubbi B, Mercurio B, Ducceschi V, Russo MG, Calabrò R (2004) A multisite atrioventricular block. Ital Heart J 5(1):64–68 PMID: 15080584
pubmed: 15080584
Broberg CS, van Dissel A, Minnier J, Aboulhosn J, Kauling RM, Ginde S, Krieger EV, Rodriguez F 3rd, Gupta T, Shah S, John AS, Cotts T, Kay WA, Kuo M, Dwight C, Woods P, Nicolarsen J, Sarubbi B, Fusco F, Antonova P, Fernandes S, Grewal J, Cramer J, Khairy P, Gallego P, O’Donnell C, Hannah J, Dellborg M, Rodriguez-Monserrate CP, Muhll IV, Pylypchuk S, Magalski A, Han F, Lubert AM, Kay J, Yeung E, Roos-Hesselink J, Baker D, Celermajer DS, Burchill LJ, Wilson WM, Wong J, Kutty S, Opotowsky AR (2022) Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries. J Am Coll Cardiol.;80(10):951–963. https://doi.org/10.1016/j.jacc.2022.06.020 . PMID: 36049802
Greenwood RD, Rosenthal A, Sloss LJ, LaCorte M, Nadas AS (1975) Sick sinus syndrome after surgery for congenital heart disease. Circulation.;52(2):208 – 13. https://doi.org/10.1161/01.cir.52.2.208 . PMID: 1149204
Murphy JG, Gersh BJ, McGoon MD et al (1990) Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 323(24):1645–1650
doi: 10.1056/NEJM199012133232401
pubmed: 2233961
Cohen MI, Bridges ND, Gaynor JW et al (2000) Modifications to the cavopulmonary anastomosis do not eliminate early sinus node dysfunction. J Thorac Cardiovasc Surg 120:891–901
doi: 10.1067/mtc.2000.109708
pubmed: 11044315
Peters NS, Somerville J (1992) Arrhythmias after the Fontan procedure. Br Heart J 68(2):199–204
doi: 10.1136/hrt.68.8.199
pubmed: 1389738
pmcid: 1025015
Opić P, van Kranenburg M, Yap SC et al (2013) Complications of pacemaker therapy in adults with congenital heart disease: a multicenter study. Int J Cardiol 168(4):3212–3216
doi: 10.1016/j.ijcard.2013.04.114
pubmed: 23643418
Walker F, Siu SC, Woods S, Cameron DA, Webb GD, Harris L (2004) Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol 43:1894–1901. https://doi.org/10.1016/j.jacc.2003.12.044
doi: 10.1016/j.jacc.2003.12.044
pubmed: 15145118
Midha D, Chen Z, Jones DG et al (2017) Pacing in congenital heart disease - A four-decade experience in a single tertiary centre. Int J Cardiol 241:177–181
doi: 10.1016/j.ijcard.2017.02.151
pubmed: 28291620
Bowman HC, Shannon KM, Biniwale R, Moore JP (2021) Cardiac implantable device outcomes and lead survival in adult congenital heart disease. Int J Cardiol 324:52–59. https://doi.org/10.1016/j.ijcard.2020.09.027 Epub 2020 Sep 15. PMID: 32941867
doi: 10.1016/j.ijcard.2020.09.027
pubmed: 32941867
Silvetti MS, Drago F, Grutter G, De Santis A, Di Ciommo V, Ravà L (2006) Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace.;8(7):530-6. https://doi.org/10.1093/europace/eul062 . PMID: 16798767